| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778005 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2018 | 17 Pages |
Abstract
We observed that TVM is a durable treatment for prolapse and that adverse events were acceptable without severe complications at 5-year follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Enrique P. Ubertazzi, Hector F.E. Soderini, Adrian J.M. Saavedra Sanchez, Camilo Fonseca Guzman, Lucila I. Paván,